The label also carries a dedicated warning, section 5.7, for severe gastrointestinal adverse reactions, which were reported more frequently among treated patients (0.4% at 0.5 mg, 0.8% at 1 mg) than placebo (0%)
Patients with a history of thyroid cancer or diabetic retinopathy should discuss these conditions with their healthcare provider due to the risk of thyroid tumors
If you receive a prescription for a weight loss medication and want to use your insurance benefits to help cover the cost, your insurance company may require a prior authorization
Over time, patients see visibly lighter, more even skin tone with improved texture
Lpidos en ayuno y postprandial: Semaglutida comparada con placebo, redujo las concentraciones de triglicridos y colesterol de lipoprotenas de muy baja densidad (VLDL) en ayuno en 12% y 21% respectivamente
Iron homeostasis and ferroptosis in human diseases Imbalances in iron homeostasis are significantly correlated with the onset and progression of various diseases